StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) income statement

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics, Inc. financial ratios

See a number that looks wrong?